The Effect of Combined Decongestive Therapy and Pneumatic Compression Pump on Body Image in Patients With Lymphedema
Lymphedema

About this trial
This is an interventional treatment trial for Lymphedema focused on measuring Lymphedema secondary to breast cancer, Breast cancer, Body image
Eligibility Criteria
Inclusion criteria:
- histoty of breast cancer,
- history of surgery and chemotherapy and as needed hormone therapy and radiotherapy,
- affected by lymphedema (with degree of mild to severe) based on specialist diagnosis,
- at least 1 year ago was undergone axillary node dissection,
- do not have knowledge about combined decongestive therapy,
- phone accessibility,
- 35-70 years old.
Exclusion criteria:
- psychotic disorder,
- existence sever pain at axillary area,
- history of hysterectomy duo to uterus cancer,
- severe cardiac disease,
- heart failure,
- renal failure,
- severe hypertension,
- existing other malignancies,
- recurrent infection in arm,
- musclo skeletal disease
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
CDT and pneumatic compression pump
not CDT and pneumatic compression pump
combined decongestive therapy consists of the pressure of bandage, manual lymphatic drainage, and exercises that increase the flow of lymph and skin care are used. Intermittent pneumatic pump is not as a part of CDT, but it can be used as an adjunct method. This device according to a specific program is air filled and emptied. The device leads the lymphatic fluid from distal to the proximal part of extremities and then to the trunk.
Patients in the control group received no treatment for lymphedema but were placed on the waiting list for CDT as soon as possible after the 8 weeks follow-up period.